[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.119.60. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
May 13, 1998

Hypoglycemia From Glipizide and Glyburide

Author Affiliations
 

Margaret A.WinkerMD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Senior EditorIndividualAuthor

JAMA. 1998;279(18):1441-1443. doi:10-1001/pubs.JAMA-ISSN-0098-7484-279-18-jac80006

To the Editor.—The study by Dr Burge and colleagues1 helps to establish that in the debate over the possible risks of hypoglycemia with sulfonylureas, a concern should not be the drug but rather the recipient. Indeed, the characteristic of the patients with type 2 diabetes mellitus included in the study is highlighted by a simple key word, healthy. Exclusion criteria were the presence of severe cardiovascular, gastrointestinal, renal, or hepatic disease, malignancies, or concurrent medications. Quite the contrary, the typical patient with type 2 diabetes is not a healthy one.

First Page Preview View Large
First page PDF preview
First page PDF preview
×